Publications by authors named "F Bergamaschi"

This study aims to evaluate the impact of COVID-19 on new renal carcinoma (RC) diagnoses using data from the Reggio Emilia Cancer Registry in 2018-2020. A total of 293 RCs were registered, with roughly 100 cases yearly. The distribution by age shows a significant decrease in the 30-59 age group (33.

View Article and Find Full Text PDF

The occurrence of asymptomatic bacteriuria concomitant to urolithiasis is an issue for patients undergoing renal stone treatment. Disposing of a preoperative urine culture is essential to reduce the risk of septic events. The endpoint of the study is to report which characteristics of candidates for renal stone treatment are frequently associated with positive urine culture.

View Article and Find Full Text PDF
Article Synopsis
  • Obesity is a major health issue affecting both adults and children, with lifestyle changes like diet and exercise being the primary treatment methods, though often ineffective.
  • Pharmacological treatments for obesity in children can be considered only when lifestyle modifications have failed, and this review focuses on current approved and experimental medications for pediatric patients.
  • The study highlights the need for more research on the safety and effectiveness of new medications to enhance weight management strategies for children and prevent obesity-related health problems.
View Article and Find Full Text PDF

In the Lombardy Region, Italy, HPV vaccination is recommended and offered free of charge to 12-years-old males since 2017. The expected vaccination thresholds are still far to be reached. A cross-sectional survey to investigate parents' attitudes towards the HPV vaccine and knowledge about HPV was administered to parents of boys aged 6 to 18 years attending a large pediatric hospital for outpatient specialistic evaluations.

View Article and Find Full Text PDF
Article Synopsis
  • A study characterized pediatric antibiotic-associated neutropenia by examining various treatment options and their timing in a clinical context, utilizing data from the FDA Adverse Event Reporting System (FAERS), chart reviews, and literature.
  • Researchers analyzed 281 events linked to antibiotics, finding that the median time to onset (TTO) of neutropenia varied, with shorter TTOs documented in retrospective reviews compared to broader literature.
  • While most cases of antibiotic-associated neutropenia are benign, the condition can occasionally lead to serious outcomes, highlighting the importance of clinician awareness for effective monitoring and patient safety.
View Article and Find Full Text PDF